Journal of Clinical Neuromuscular Disease
SJR0.282
US
USJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.282 | Q3 | 41.2% | |
| 2024 | — | — | 0.394 | Q3 | 54.5% | |
| 2023 | — | — | 0.274 | Q3 | 46.0% | |
| 2022 | — | — | 0.224 | Q4 | 41.3% | |
| 2021 | — | — | 0.308 | Q3 | 52.2% | |
| 2020 | — | — | 0.466 | Q3 | 64.2% | |
| 2019 | — | — | 0.407 | Q3 | 61.5% | |
| 2018 | — | — | 0.357 | Q3 | 55.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
1522-0443
ISSN
1537-1611
country
UScoverage
1999-2025